These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8582046)

  • 21. Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist.
    Zucchini S; Buzzi A; Bergamaschi M; Pietra C; Villetti G; Simonato M
    Neuroreport; 2002 Nov; 13(16):2071-4. PubMed ID: 12438928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of inhibiting N-methyl-D-aspartate receptors, P2X receptors and the mitogen-activated protein kinase cascade: a quantitative analysis in organotypical hippocampal slice cultures subjected to oxygen and glucose deprivation.
    Rundén-Pran E; Tansø R; Haug FM; Ottersen OP; Ring A
    Neuroscience; 2005; 136(3):795-810. PubMed ID: 16344152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzoazepine derivative as potent antagonists of the glycine binding site associated to the NMDA receptor.
    Di Fabio R; Micheli F; Baraldi D; Bertani B; Conti N; Dal Forno G; Feriani A; Donati D; Marchioro C; Messeri T; Missio A; Pasquarello A; Pentassuglia G; Pizzi DA; Provera S; Quaglia AM; Sabbatini FM
    Farmaco; 2003 Sep; 58(9):723-38. PubMed ID: 13679166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization.
    Conti P; Pinto A; Tamborini L; Madsen U; Nielsen B; Bräuner-Osborne H; Hansen KB; Landucci E; Pellegrini-Giampietro DE; De Sarro G; Donato Di Paola E; De Micheli C
    ChemMedChem; 2010 Sep; 5(9):1465-75. PubMed ID: 20665761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, resolution, and SAR of (+/-)-2-amino-N-methyl-alpha-(3-methyl-2-thienyl)benzeneethanamine++ + and related analogs as noncompetitive NMDA antagonists with neuroprotective properties.
    Martin LL; Lee GE; Lee TB; Rush DK; Wilmot CA; Paulus E; Elben U; Grome JJ; Porsche-Wiebking E; Rudolphi KA
    J Med Chem; 1994 Sep; 37(19):3008-15. PubMed ID: 7932522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor.
    Weaver CE; Marek P; Park-Chung M; Tam SW; Farb DH
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10450-4. PubMed ID: 9294231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats.
    Iwasaki K; Chung EH; Egashira N; Hatip-Al-Khatib I; Mishima K; Egawa T; Irie K; Fujiwara M
    Brain Res; 2004 Jan; 995(1):131-9. PubMed ID: 14644478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats.
    Folbergrová J
    Exp Neurol; 1994 Dec; 130(2):344-50. PubMed ID: 7867764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: a potent and stereoselective NMDA receptor antagonist.
    Moe ST; Shimizu SM; Smith DL; Van Wagenen BC; DelMar EG; Balandrin MF; Chien Y; Raszkiewicz JL; Artman LD; Mueller AL; Lobkovsky E; Clardy J
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1915-20. PubMed ID: 10450953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral and metabolic changes in immature rats during seizures induced by homocysteic acid: the protective effect of NMDA and non-NMDA receptor antagonists.
    Folbergrová J; Haugvicová R; Mares P
    Exp Neurol; 2000 Jan; 161(1):336-45. PubMed ID: 10683299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
    Conti P; De Amici M; Joppolo Di Ventimiglia S; Stensbøl TB; Madsen U; Bräuner-Osborne H; Russo E; De Sarro G; Bruno G; De Micheli C
    J Med Chem; 2003 Jul; 46(14):3102-8. PubMed ID: 12825948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anticonvulsant properties of tetrahydroisoquinoline derivatives.
    Gitto R; Caruso R; Orlando V; Quartarone S; Barreca ML; Ferreri G; Russo E; De Sarro G; Chimirri A
    Farmaco; 2004 Jan; 59(1):7-12. PubMed ID: 14751310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat.
    Sarraf-Yazdi S; Sheng H; Miura Y; McFarlane C; Dexter F; Pearlstein R; Warner DS
    Anesth Analg; 1998 Jul; 87(1):72-8. PubMed ID: 9661549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.
    Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ
    J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors.
    Giovannelli L; Cozzi A; Guarnieri I; Dolara P; Moroni F
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):697-704. PubMed ID: 12045668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
    Hicks CA; Ward MA; Swettenham JB; O'Neill MJ
    Eur J Pharmacol; 1999 Sep; 381(2-3):113-9. PubMed ID: 10554878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia.
    Pringle AK; Iannotti F; Wilde GJ; Chad JE; Seeley PJ; Sundstrom LE
    Brain Res; 1997 Apr; 755(1):36-46. PubMed ID: 9163539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats.
    McAllister KH
    Eur J Pharmacol; 1996 Oct; 314(3):307-11. PubMed ID: 8957251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.